
Stellest 2.0 improved effect on axial elongation
A new clinical study found Essilor Stellest 2.0 spectacle lenses with highly aspherical lenslet target (HALT) MAX technology offer significantly higher efficacy in slowing axial elongation compared w
4201 articles

A new clinical study found Essilor Stellest 2.0 spectacle lenses with highly aspherical lenslet target (HALT) MAX technology offer significantly higher efficacy in slowing axial elongation compared w

IMI's new White Paper: Evidence from animal and human studies confirms outdoor time as a key strategy for delaying myopia onset.

The term ‘compassion fatigue’ is often applied as the personal cost of caring, but new research from the University of Auckland suggests the phenomenon could in fact be a self-fulfilling prophecy.

A new study associated virtual reality (VR) headset use with a reduced risk of dry eye in healthy patients, which authors said is due to elevated temperature inside the headset. While previous

Researchers at the UK’s Aston University will assess how screen use affects babies and their families during the first 1,001 days of life. The work, commissioned by the 1001 Critical Days Foundatio

True to its original and colourful spirit, Dutz’s 2026 sunglass collection is bold, stylish and unapologetically expressive, announced the brand. With lots of different easy-to-wear shapes for him and her, Dutz has got colour for everyone.

Kim Down has joined the Ophthalmology New Zealand (ONZ) team as executive assistant, supporting CEO Moira McInerney.

Woodys’ Atelier collection offers a one-of-a-kind eyewear defined by bold, edgy and innovative design. Each handcrafted piece plays with volumes, laminates, patterns and colours to create sculptural frames that evoke emotion and empower the wearer, the company said. Built using more than 150 meticul

Optica Life Accessories has acquired Australian optical accessories supplier KE Optical, expanding its reach across Australia and New Zealand.

A South Auckland pilot programme found community pharmacists, working with general practice nurses, significantly lowered and sustained blood glucose levels in patients with type 2 diabetes (T2D).

US researchers have launched a national clinical trial to test whether low-dose atropine eye drops can prevent the development of myopia in children.

Optometry Australia (OA) has appointed Mark Nevin (pictured) as its new chief executive officer, following the departure of outgoing CEO Skye Cappuccio. OA president, Theo Charalambous, said